What are the adverse effects and contraindications of each diuretic class (loop, thiazide, potassium‑sparing, carbonic anhydrase inhibitor, and osmotic diuretics)?

Adverse Effects and Contraindications of Diuretic Classes

All diuretic classes share common risks of electrolyte depletion, fluid depletion, hypotension, and azotemia, but each class has distinct adverse effect profiles and contraindications that must be carefully monitored. 1

Loop Diuretics (Furosemide, Bumetanide, Torsemide)

Adverse Effects

• Electrolyte disturbances: Hypokalemia, hypomagnesemia, hyponatremia 2
• Metabolic effects: Hyperuricemia, glucose intolerance 2
• Acid-base disturbances: Metabolic alkalosis 2
• Ototoxicity: Hearing difficulties, particularly with very large doses 1
• Renal effects: Dose-dependent renal decline, with higher doses causing more rapid eGFR decline 3
• Cardiovascular: Associated with increased mortality risk and hospital admissions when used long-term in heart failure 3

Contraindications

• Not recommended as first-line therapy for hypertension (no outcome data supporting their use) 4
• Should be avoided in patients with severe volume depletion
• Use with extreme caution in patients with hepatic cirrhosis (risk of precipitating hepatic encephalopathy)

Monitoring Requirements

Check electrolytes, renal function 1-2 weeks after initiation, then at 3 months, and subsequently at 6-month intervals 2

---

Thiazide/Thiazide-Like Diuretics (Hydrochlorothiazide, Chlorthalidone, Indapamide)

Adverse Effects

• Electrolyte disturbances: Hypokalemia (increases blood glucose), hypomagnesemia, hyponatremia 5, 2
• Metabolic effects: Hyperuricemia, glucose intolerance, precipitation of diabetes (particularly with hydrochlorothiazide) 2, 4, 6
• Acid-base disturbances: Metabolic alkalosis 2
• Sexual dysfunction: Impotence (mechanism not fully understood) 4
• Dermatologic: Rashes 1
• Renal: Azotemia, particularly chlorthalidone in patients with renal disease 5

Contraindications

• GFR <30 mL/min: Thiazides ineffective as monotherapy; should only be used synergistically with loop diuretics 2
• Severe renal impairment: Chlorthalidone may precipitate azotemia and should be used with caution 5
• Avoid in patients with symptomatic hyperuricemia or gout (unless using allopurinol concurrently) 4

Critical Monitoring Points

• Hypokalemia must be avoided in patients on thiazide monotherapy 7, 8
• Thiazide-induced hypokalemia is associated with increased blood glucose; treating the hypokalemia may reverse glucose intolerance 4
• Check electrolytes 2-4 weeks after initiation or dose changes 9

---

Potassium-Sparing Diuretics (Amiloride, Triamterene, Spironolactone, Eplerenone)

Adverse Effects

• Hyperkalemia: The most serious and life-threatening adverse effect, particularly when combined with ACE inhibitors or ARBs 5, 10, 11, 2
• Spironolactone-specific: Gynaecomastia 2
• Amiloride-specific: Rash 2
• Renal dysfunction: Prolonged spironolactone use can increase risk of developing CKD 3

Contraindications

• Serum potassium ≥5.0-5.2 mEq/L 10, 11
• Severe renal impairment: Creatinine >2.5 mg/dL in men or >2.0 mg/dL in women (or eGFR <30 mL/min/1.73 m²) 10, 11
• Concurrent use with ACE inhibitors or ARBs without close monitoring 5, 10
• Should be avoided during initiation of ACE inhibitor therapy 2

Monitoring Requirements

Stringent monitoring is mandatory: Check serum potassium and creatinine after 5-7 days of initiation, recheck every 5-7 days until stable 2. For aldosterone antagonists in heart failure, careful monitoring at initiation and close follow-up thereafter to minimize hyperkalemia and renal insufficiency risk 11. Serum potassium >5.5 mmol/L is a main predictor for mortality in heart failure inpatients 3.

---

Carbonic Anhydrase Inhibitors (Acetazolamide)

Adverse Effects

• Metabolic acidosis: Due to bicarbonate loss
• Electrolyte disturbances: Hypokalemia
• CNS effects: Paresthesias, drowsiness, confusion
• Renal: Nephrolithiasis (calcium phosphate stones)

Contraindications

• Severe hepatic disease (risk of hepatic encephalopathy)
• Severe renal impairment
• Hyperchloremic acidosis
• Adrenal insufficiency

Current Use

Not used as diuretics in contemporary practice; primarily reserved for glaucoma treatment and correction of metabolic alkalosis 12, 13

---

Osmotic Diuretics (Mannitol)

Adverse Effects

• Volume overload: Initial plasma volume expansion before diuresis
• Electrolyte disturbances: Hyponatremia, hyperkalemia (from cellular shifts)
• Renal: Osmotic nephrosis with high doses
• Cardiovascular: Pulmonary edema, heart failure exacerbation
• Neurologic: Rebound intracranial hypertension

Contraindications

• Anuria due to severe renal disease
• Severe pulmonary edema or congestion
• Active intracranial bleeding
• Severe dehydration
• Progressive heart failure

Specific Use

Reserved for acute situations (cerebral edema, acute glaucoma, forced diuresis for toxin elimination); not used for chronic hypertension or heart failure management.

---

Critical Drug Interactions Across All Classes

• NSAIDs: Blunt diuretic effects, increase risk of renal dysfunction 2, 4
• Beta-blockers + thiazides: May increase fatigue, lethargy, and glucose elevation 4
• ACE inhibitors/ARBs + potassium-sparing diuretics: Severe hyperkalemia risk 5, 10, 11
• Digoxin + diuretics causing hypokalemia: Increased risk of serious cardiac arrhythmias 1

---

Common Pitfalls to Avoid

1. Using loop diuretics as first-line for hypertension without heart failure or renal failure 4
2. Failing to monitor electrolytes shortly after initiating therapy 5
3. Combining ACE inhibitors/ARBs with potassium-sparing diuretics without rigorous potassium monitoring 10, 11
4. Using thiazides in patients with GFR <30 mL/min as monotherapy 2
5. Ignoring hypokalemia in patients on thiazide monotherapy, which increases diabetes risk 7, 8, 4